ESTRO Brachytherapy for Prostate Cancer 2018

Literature shows significant heterogeneity o of the patient populations o in the risk categories o in the definition of risk factors

o in the follow-up time o in ADT administration o in the duration for ADT administration

The retrospective analyses induces unavoidable patient selection and treatment selection bias !